Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

Asaf Danziger Biography and Net Worth

CEO of NovoCure

Asaf Danziger has served as Chief Executive Officer of Novocure since 2002 and has been a director of Novocure since 2012. Mr. Danziger has led the company and the development of TTFields therapy from preclinical testing through regulatory approvals to commercial sales in Europe and the United States. From 1998 to 2002, Mr. Danziger was Chief Executive Officer of Cybro Medical, a subsidiary of Imagyn Medical Technologies. Mr. Danziger holds a B.Sc. in material engineering from Ben Gurion University of the Negev, Israel.

What is Asaf Danziger's net worth?: The estimated net worth of Asaf Danziger is at least $166,120.09 as of January 5th, 2023. Mr. Danziger owns 13,583 shares of NovoCure stock worth more than $166,120 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Danziger may own. Additionally, Mr. Danziger receives a salary of $1,700,000.00 as CEO at NovoCure. Learn More about Asaf Danziger's net worth.
How old is Asaf Danziger?: Mr. Danziger is currently 58 years old. There are 7 older executives and no younger executives at NovoCure. Learn More on Asaf Danziger's age.
What is Asaf Danziger's salary?: As the CEO of NovoCure Limited, Mr. Danziger earns $1,700,000.00 per year. Learn More on Asaf Danziger's salary.
How do I contact Asaf Danziger?: The corporate mailing address for Mr. Danziger and other NovoCure executives is NO. 4 THE FORUM GRENVILLE STREET, ST. HELIER Y9, JE2 4UF. NovoCure can also be reached via phone at 441534756700 and via email at [email protected]. Learn More on Asaf Danziger's contact information.
Has Asaf Danziger been buying or selling shares of NovoCure?: Asaf Danziger has not been actively trading shares of NovoCure over the course of the past ninety days. Most recently, Asaf Danziger sold 212,500 shares of the business's stock in a transaction on Thursday, January 5th. The shares were sold at an average price of $108.74, for a transaction totalling $23,107,250.00. Following the completion of the sale, the chief executive officer now directly owns 13,583 shares of the company's stock, valued at $1,477,015.42. Learn More on Asaf Danziger's trading history.
Who are NovoCure's active insiders?: NovoCure's insider roster includes Michael Ambrogi (COO), Ely Benaim (Insider), Ashley Cordova (CFO), Asaf Danziger (CEO), William Doyle (Chairman), Wilhelmus Groenhuysen (COO), Jeryl Hilleman (Director), Frank Leonard (Insider), Gabriel Leung (Director), Todd Longsworth (General Counsel), Martin Madden (Director), Pritesh Shah (Insider), and Uri Weinberg (Insider). Learn More on NovoCure's active insiders.
Are insiders buying or selling shares of NovoCure?: During the last twelve months, insiders at the medical equipment provider sold shares 9 times. They sold a total of 9,753 shares worth more than $163,632.37. The most recent insider tranaction occured on March, 4th when EVP Frank X Leonard sold 840 shares worth more than $13,448.40. Insiders at NovoCure own 5.7% of the company. Learn More about insider trades at NovoCure.
Information on this page was last updated on 3/4/2024.

Asaf Danziger Insider Trading History at NovoCure

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/5/2023	Sell	212,500	$108.74	$23,107,250.00	13,583
11/26/2021	Buy	4,974	$102.44	$509,536.56
4/13/2021	Sell	97,973	$196.34	$19,236,018.82
12/18/2020	Sell	207,910	$157.39	$32,722,954.90	301,587
11/25/2019	Sell	103,000	$95.00	$9,785,000.00	237,601
8/29/2019	Sell	124,181	$91.13	$11,316,614.53	200,869
6/28/2019	Sell	187,500	$62.15	$11,653,125.00	445,811
6/18/2019	Sell	190,338	$59.37	$11,300,367.06	448,649
6/12/2019	Sell	30,436	$55.39	$1,685,850.04	275,146
3/4/2019	Sell	16,268	$55.89	$909,218.52	250,025
2/28/2019	Sell	903	$54.40	$49,123.20	233,757
2/13/2019	Sell	50,000	$51.46	$2,573,000.00
1/23/2019	Sell	88,695	$47.48	$4,211,238.60	259,859
1/17/2019	Sell	100,000	$45.26	$4,526,000.00	271,164
1/15/2019	Sell	200,000	$43.51	$8,702,000.00	271,164
6/27/2018	Sell	70,364	$32.09	$2,257,980.76	69,318
6/20/2018	Sell	8,308	$32.04	$266,188.32	147,990
6/18/2018	Sell	22,289	$32.00	$713,248.00	147,990
6/14/2018	Sell	11,920	$32.00	$381,440.00	171,100
6/4/2018	Sell	227,304	$29.09	$6,612,273.36	260,246
1/29/2018	Sell	13,974	$24.02	$335,655.48	356,790
1/24/2018	Sell	20,848	$22.10	$460,740.80	387,820
1/16/2018	Sell	14,900	$22.20	$330,780.00	398,068
1/12/2018	Sell	336,420	$22.33	$7,512,258.60	435,863
11/6/2017	Sell	6,919	$22.00	$152,218.00
11/3/2017	Sell	2,300	$22.00	$50,600.00	756,024
11/1/2017	Sell	15,866	$22.01	$349,210.66	774,040
9/25/2017	Sell	900	$22.05	$19,845.00	774,190
9/14/2017	Sell	37,272	$22.01	$820,356.72	776,862
9/13/2017	Sell	35,500	$22.01	$781,355.00	776,862
7/11/2017	Sell	7,383	$19.95	$147,290.85	462,765
7/10/2017	Sell	274,359	$18.07	$4,957,667.13	668,865
7/6/2017	Sell	160,138	$18.14	$2,904,903.32	899,462
7/5/2017	Sell	155,088	$18.14	$2,813,296.32	899,462
6/19/2017	Sell	124,720	$15.51	$1,934,407.20	896,917
6/16/2017	Sell	42,457	$15.15	$643,223.55	1,030,849
6/14/2017	Sell	94,102	$15.22	$1,432,232.44	1,069,496
6/12/2017	Sell	180,601	$15.13	$2,732,493.13	1,163,296
3/3/2016	Buy	10,000	$15.00	$150,000.00	933,557

Asaf Danziger Buying and Selling Activity at NovoCure

NovoCure Company Overview

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Today's Range

Now: $12.23

$11.88

$12.36

50 Day Range

MA: $14.57

$11.83

$17.29

2 Week Range

Now: $12.23

$10.87

$83.60

Volume

1,008,296 shs

Average Volume

1,342,746 shs

Market Capitalization

$1.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

See why the elites are pouring billions into gold.

Asaf Danziger Biography and Net Worth

What is Asaf Danziger's net worth?

How old is Asaf Danziger?

What is Asaf Danziger's salary?

How do I contact Asaf Danziger?

Has Asaf Danziger been buying or selling shares of NovoCure?

Who are NovoCure's active insiders?

Are insiders buying or selling shares of NovoCure?